• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ATRICURE, INC. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX Back to Search Results
Model Number CDK-1413
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Perforation of Esophagus (2399)
Event Date 12/17/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4): the device was not returned for evaluation and a device history review was unable to be completed as the relevant lot number for the epi-sense device was not reported or able to be subsequently ascertained.The complaint could not be confirmed.
 
Event Description
It was reported that on (b)(6) 2018 a (b)(6) female patient underwent convergent procedure.The surgical procedure seemed to go well intraoperatively; tee was clear of thrombus, circa temperature probe was placed in the esophagus and was monitored throughout the case, adhesions were present on the posterior left atrium.Ablations were performed on all viable tissue with epi-sense catheter until no more tissue on the posterior la could be reached.Patient was taken to ep lab same day where a voltage map was performed along with rf ablation touch ups near the pulmonary veins and along the roof, extensively in the right superior region of the posterior la where adhesions prohibited epicardial ablation.Procedure was completed without any known issues, patient was doing well and in sinus rhythm as of last follow up last week.Patient was brought into er two days ago ((b)(6) 2018) with gi bleeding with either of the "cardiothoraciac" surgeons being notified.Patient had an endoscopy done at the hospital, to which the now known atrio esophageal fistula was likely made much worse.Patient was brought back into the operating room later that night and aef was repaired.Patient underwent an esophagectomy earlier that morning.The patient expired the week of (b)(6) 2018.This was a procedural complication.There was no reported device malfunction.
 
Manufacturer Narrative
Case- (b)(4) correction made to patient information- patient age in years added.
 
Manufacturer Narrative
(b)(4): per additional information received, the circa probe was not used during the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Type of Device
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX
Manufacturer (Section D)
ATRICURE, INC.
7555 innovation way
mason OH 45040
MDR Report Key8243764
MDR Text Key132919957
Report Number3011706110-2019-00005
Device Sequence Number1
Product Code OCL
Combination Product (y/n)N
PMA/PMN Number
K142084
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 05/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/14/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCDK-1413
Device Catalogue NumberCDK-1413
Was Device Available for Evaluation? No
Date Manufacturer Received12/19/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age80 YR
-
-